These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors. Uygun A; Kadayifci A; Polat Z; Yilmaz K; Gunal A; Demir H; Bagci S J Surg Oncol; 2014 Feb; 109(2):71-4. PubMed ID: 24165913 [TBL] [Abstract][Full Text] [Related]
6. Multiple gastric G1 neuroendocrine tumors with venous and lymphatic invasion. Tatsuta T; Yoshimura T; Hasui K; Takasugi K; Sawaya M; Hanabata N; Shimoyama T; Kijima H; Fukuda S Intern Med; 2013; 52(15):1697-701. PubMed ID: 23903502 [TBL] [Abstract][Full Text] [Related]
7. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases]. Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793 [TBL] [Abstract][Full Text] [Related]
9. The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: our experience: a case report. Cavallaro A; Zanghì A; Cavallaro M; Lo Menzo E; Di Carlo I; Di Vita M; Cardì F; Piccolo G; Di Mattia P; Cappellani A Int J Surg; 2014; 12 Suppl 1():S225-31. PubMed ID: 24862665 [TBL] [Abstract][Full Text] [Related]
10. The biological relevance of gastric neuroendocrine tumors. Klöppel G; Clemens A Yale J Biol Med; 1996; 69(1):69-74. PubMed ID: 9041691 [TBL] [Abstract][Full Text] [Related]
11. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment]. Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645 [TBL] [Abstract][Full Text] [Related]
12. Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours. Murugesan SV; Steele IA; Dimaline R; Poston GJ; Shrotri M; Campbell F; Varro A; Pritchard DM Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):474-81. PubMed ID: 23249603 [TBL] [Abstract][Full Text] [Related]
13. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269 [TBL] [Abstract][Full Text] [Related]
14. Two Types of Gastric Cancer Caused by the Same Underlying Condition. Rustgi N; Shroff SG; Katona BW Gastroenterology; 2018 Apr; 154(5):1246-1248. PubMed ID: 29410354 [No Abstract] [Full Text] [Related]
16. [Neuroendocrine tumors of the stomach. Surgery therapy and prognosis]. Bektas H; Länger F; Piso P; Werner U; Musholt TJ; Lehner F; Becker T; Klempnauer J Chirurg; 2002 Apr; 73(4):331-5. PubMed ID: 12063917 [TBL] [Abstract][Full Text] [Related]
17. [Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: good prognosis with early detection]. Scherübl H; Faiss S; Jahn HU; Liehr RM; Schwertner C; Steinberg J; Stölzel U; Weinke T; Zimmer T; Klöppel G Dtsch Med Wochenschr; 2009 Jul; 134(30):1529-35. PubMed ID: 19603370 [TBL] [Abstract][Full Text] [Related]
18. Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience. Chen WC; Warner RR; Ward SC; Harpaz N; Divino CM; Itzkowitz SH; Kim MK Dig Dis Sci; 2015 Apr; 60(4):996-1003. PubMed ID: 25399327 [TBL] [Abstract][Full Text] [Related]
19. Management of Other Gastric and Duodenal Neuroendocrine Tumors. Laird AM; Libutti SK Surg Oncol Clin N Am; 2020 Apr; 29(2):253-266. PubMed ID: 32151359 [TBL] [Abstract][Full Text] [Related]
20. An atypical type I gastric neuroendocrine tumor. Gheorghe AV; Rimbas M; Ginghina O; Spanu A; Voiosu TA Rom J Intern Med; 2017 Dec; 55(4):253-256. PubMed ID: 28710883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]